American scientists from the research center Kaiser Permanente Washington Research Institute in Seattle began testing a vaccine against the coronavirus in humans, the Associated Press reports. Trials of the vaccine type 45 volunteers, two doses each at an interval of a month.
According to the newspaper, you will need a whole series of studies and tests in order to confirm the safety and efficacy of the vaccine. Widespread use of the vaccine should not expect earlier than 12-18 months.
the name of the vaccine – mRNA-1273, it was developed by the National Institute of health, USA and the Moderna biotech Inc. In addition, next month can begin tests of another vaccine developed by Inovio Pharmaceuticals.
In Russia also are developing their version of a vaccine against a new type of coronavirus. In early March, Deputy Prime Minister Tatiana Golikova promised to accelerate the development of these drugs. According to her, Russia is developing a vaccine in five areas and 13 options. Prior to that, Vice Prime Minister reported that Russia managed to obtain the strain of the new virus, but it did not specify who provided it. In St.-Petersburg research Institute of vaccines and serums FMBA reported that the vaccine may appear in the third quarter of 2020, and the fourth may begin animal studies.